These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 11848208

  • 1. Studies of rapidly disintegrating tablets in the oral cavity using co-ground mixtures of mannitol with crospovidone.
    Shu T, Suzuki H, Hironaka K, Ito K.
    Chem Pharm Bull (Tokyo); 2002 Feb; 50(2):193-8. PubMed ID: 11848208
    [Abstract] [Full Text] [Related]

  • 2. A new formulation for orally disintegrating tablets using a suspension spray-coating method.
    Okuda Y, Irisawa Y, Okimoto K, Osawa T, Yamashita S.
    Int J Pharm; 2009 Dec 01; 382(1-2):80-7. PubMed ID: 19686825
    [Abstract] [Full Text] [Related]

  • 3. Development of a Novel Co-processed Excipitient Comprising of Xylitol, Mannitol, Microcrystalline Cellulose, and Crospovidone for the Compounding of Memantine Hydrochloride Orally Disintegrating Tablet.
    Hazdi SN, Phang HC, Ng ZQ, Chew YL, Uddin AH, Sarker ZI, Lee SK, Liew KB.
    Int J Pharm Compd; 2023 Dec 01; 27(6):522-527. PubMed ID: 38100670
    [Abstract] [Full Text] [Related]

  • 4. Influence of sodium starch glycolate, croscarmellose sodium and crospovidone on disintegration and dissolution of stevia-loaded tablets.
    Yousaf AM, Naheed F, Shahzad Y, Hussain T, Mahmood T.
    Polim Med; 2019 Dec 01; 49(1):19-26. PubMed ID: 31756060
    [Abstract] [Full Text] [Related]

  • 5. Microwave-Assisted Development of Orally Disintegrating Tablets by Direct Compression.
    Kande KV, Kotak DJ, Degani MS, Kirsanov D, Legin A, Devarajan PV.
    AAPS PharmSciTech; 2017 Aug 01; 18(6):2055-2066. PubMed ID: 27995465
    [Abstract] [Full Text] [Related]

  • 6. Further improvement of orally disintegrating tablets using micronized ethylcellulose.
    Okuda Y, Irisawa Y, Okimoto K, Osawa T, Yamashita S.
    Int J Pharm; 2012 Feb 28; 423(2):351-9. PubMed ID: 22138608
    [Abstract] [Full Text] [Related]

  • 7. Orally Disintegrating Tablet Manufacture via Direct Powder Compression Using Cellulose Nanofiber as a Functional Additive.
    Nakamura S, Fukai T, Sakamoto T.
    AAPS PharmSciTech; 2021 Dec 23; 23(1):37. PubMed ID: 34950985
    [Abstract] [Full Text] [Related]

  • 8. Application of general multilevel factorial design with formulation of fast disintegrating tablets containing croscaremellose sodium and Disintequick MCC-25.
    Solaiman A, Suliman AS, Shinde S, Naz S, Elkordy AA.
    Int J Pharm; 2016 Mar 30; 501(1-2):87-95. PubMed ID: 26827922
    [Abstract] [Full Text] [Related]

  • 9. Functionality of disintegrants and their mixtures in enabling fast disintegration of tablets by a quality by design approach.
    Desai PM, Er PX, Liew CV, Heng PW.
    AAPS PharmSciTech; 2014 Oct 30; 15(5):1093-104. PubMed ID: 24848762
    [Abstract] [Full Text] [Related]

  • 10. Design and evaluation of microwave-treated orally disintegrating tablets containing polymeric disintegrant and mannitol.
    Sano S, Iwao Y, Noguchi S, Kimura S, Itai S.
    Int J Pharm; 2013 May 01; 448(1):132-41. PubMed ID: 23524122
    [Abstract] [Full Text] [Related]

  • 11. In vitro determination of aceclofenac Mouth Dissolving Tablets.
    Shobhit S, Gupta SK.
    Polim Med; 2013 May 01; 43(4):227-9. PubMed ID: 24596037
    [Abstract] [Full Text] [Related]

  • 12. Improvement of dissolution rate and oral bioavailability of a sparingly water-soluble drug, (+/-)-5-[[2-(2-naphthalenylmethyl)-5-benzoxazolyl]-methyl]- 2, 4-thiazolidinedione, in co-ground mixture with D-mannitol.
    Kubo H, Mizobe M.
    Biol Pharm Bull; 1997 Apr 01; 20(4):460-3. PubMed ID: 9145232
    [Abstract] [Full Text] [Related]

  • 13. Characterization, optimisation and process robustness of a co-processed mannitol for the development of orally disintegrating tablets.
    Soh JL, Grachet M, Whitlock M, Lukas T.
    Pharm Dev Technol; 2013 Feb 01; 18(1):172-85. PubMed ID: 22582882
    [Abstract] [Full Text] [Related]

  • 14. PREPARATION AND CHARACTERIZATION OF ORALLY DISINTEGRATING LORATADINE TABLETS MANUFACTURED WITH CO-PROCESSED MIXTURES.
    Amelian A, Szekalska M, Wilczewska AZ, Basa A, Winnicka K.
    Acta Pol Pharm; 2016 Feb 01; 73(2):453-60. PubMed ID: 27180438
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of the compaction properties of a solid dispersion of indomethacin with crospovidone by tableting process analyzer.
    Shibata Y, Fujii M, Okada H, Noda S, Kondoh M, Watanabe Y.
    Chem Pharm Bull (Tokyo); 2005 Jul 01; 53(7):759-63. PubMed ID: 15997130
    [Abstract] [Full Text] [Related]

  • 16. Preparation of orally disintegrating tablets with taste-masking function: masking effect in granules prepared with correctives using the dry granulation method and evaluation of tablets prepared using the taste-masked granules.
    Kawano Y, Ito A, Sasatsu M, Machida Y.
    Yakugaku Zasshi; 2010 Jan 01; 130(1):81-6. PubMed ID: 20046070
    [Abstract] [Full Text] [Related]

  • 17. Amorphous Formulation and in Vitro Performance Testing of Instantly Disintegrating Buccal Tablets for the Emergency Delivery of Naloxone.
    Alqurshi A, Kumar Z, McDonald R, Strang J, Buanz A, Ahmed S, Allen E, Cameron P, Rickard JA, Sandhu V, Holt C, Stansfield R, Taylor D, Forbes B, Royall PG.
    Mol Pharm; 2016 May 02; 13(5):1688-98. PubMed ID: 26977787
    [Abstract] [Full Text] [Related]

  • 18. Development of a multiparticulate drug delivery system for in situ amorphisation.
    Holm TP, Kokott M, Knopp MM, Boyd BJ, Berthelsen R, Quodbach J, Löbmann K.
    Eur J Pharm Biopharm; 2022 Nov 02; 180():170-180. PubMed ID: 36191869
    [Abstract] [Full Text] [Related]

  • 19. Preparation, characterization, and tableting of a solid dispersion of indomethacin with crospovidone.
    Fujii M, Okada H, Shibata Y, Teramachi H, Kondoh M, Watanabe Y.
    Int J Pharm; 2005 Apr 11; 293(1-2):145-53. PubMed ID: 15778052
    [Abstract] [Full Text] [Related]

  • 20. Fluidity and tableting characteristics of a powder solid dispersion of the low melting drugs ketoprofen and ibuprofen with crospovidone.
    Shibata Y, Fujii M, Noda S, Kokudai M, Okada H, Kondoh M, Watanabe Y.
    Drug Dev Ind Pharm; 2006 Apr 11; 32(4):449-56. PubMed ID: 16638683
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.